MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $47,000 | +6.8% | 18,700 | -14.4% | 0.00% | – |
| Q1 2020 | $44,000 | +76.0% | 21,844 | +87.8% | 0.00% | – |
| Q4 2019 | $25,000 | +525.0% | 11,634 | +278.2% | 0.00% | – |
| Q3 2019 | $4,000 | -98.6% | 3,076 | -95.5% | 0.00% | -100.0% |
| Q2 2019 | $281,000 | -73.5% | 67,823 | -73.3% | 0.00% | -66.7% |
| Q1 2019 | $1,062,000 | +376.2% | 254,199 | +226.5% | 0.00% | +200.0% |
| Q4 2018 | $223,000 | -11.5% | 77,863 | +208.4% | 0.00% | 0.0% |
| Q3 2018 | $252,000 | +31.9% | 25,244 | -49.8% | 0.00% | -87.5% |
| Q1 2018 | $191,000 | +1093.8% | 50,258 | +2394.2% | 0.01% | +700.0% |
| Q4 2017 | $16,000 | +220.0% | 2,015 | +108.6% | 0.00% | – |
| Q3 2017 | $5,000 | – | 966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |